- Home
- PCVX vs KNSL Comparison
PCVX vs KNSL Comparison
Compare PCVX & KNSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PCVX
- KNSL
- Stock Information
- Founded
- PCVX 2013
- KNSL 2009
- Country
- PCVX United States
- KNSL United States
- Employees
- PCVX N/A
- KNSL N/A
- Industry
- PCVX Biotechnology: Pharmaceutical Preparations
- KNSL Property-Casualty Insurers
- Sector
- PCVX Health Care
- KNSL Finance
- Exchange
- PCVX Nasdaq
- KNSL Nasdaq
- Market Cap
- PCVX 14.7B
- KNSL 11.0B
- IPO Year
- PCVX 2020
- KNSL 2016
- Fundamental
- Price
- PCVX $106.97
- KNSL $428.84
- Analyst Decision
- PCVX Strong Buy
- KNSL Hold
- Analyst Count
- PCVX 7
- KNSL 8
- Target Price
- PCVX $147.50
- KNSL $463.43
- AVG Volume (30 Days)
- PCVX 636.4K
- KNSL 172.6K
- Earning Date
- PCVX 11-04-2024
- KNSL 10-24-2024
- Dividend Yield
- PCVX N/A
- KNSL 0.14%
- EPS Growth
- PCVX N/A
- KNSL 50.01
- EPS
- PCVX N/A
- KNSL 17.53
- Revenue
- PCVX N/A
- KNSL $1,526,573,000.00
- Revenue This Year
- PCVX N/A
- KNSL N/A
- Revenue Next Year
- PCVX N/A
- KNSL $19.12
- P/E Ratio
- PCVX N/A
- KNSL $25.00
- Revenue Growth
- PCVX N/A
- KNSL 36.12
- 52 Week Low
- PCVX $46.16
- KNSL $325.01
- 52 Week High
- PCVX $121.06
- KNSL $548.47
- Technical
- Relative Strength Index (RSI)
- PCVX 39.76
- KNSL 36.28
- Support Level
- PCVX $102.84
- KNSL $428.39
- Resistance Level
- PCVX $115.56
- KNSL $451.94
- Average True Range (ATR)
- PCVX 3.32
- KNSL 9.98
- MACD
- PCVX -1.41
- KNSL -4.25
- Stochastic Oscillator
- PCVX 21.55
- KNSL 29.87
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a vaccine company seeking to improve global health by developing novel vaccines to treat patients suffering from the most common and deadly diseases. Its product comprises. of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-24, VAX-A1, and VAX-PG.
About KNSL Kinsale Capital Group Inc.
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, a professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.